Harbor Capital Advisors’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $940K | Sell |
30,036
-26,555
| -47% | -$831K | 0.04% | 445 |
|
|
2025
Q1 | $1.9M | Buy |
56,591
+6,773
| +14% | +$227K | 0.09% | 296 |
|
|
2024
Q4 | $1.95M | Buy |
49,818
+1,755
| +4% | +$68.8K | 0.09% | 297 |
|
|
2024
Q3 | $1.89M | Buy |
48,063
+23,947
| +99% | +$943K | 0.08% | 313 |
|
|
2024
Q2 | $940K | Buy |
24,116
+20,891
| +648% | +$814K | 0.07% | 370 |
|
|
2024
Q1 | $139K | Buy |
+3,225
| New | +$139K | 0.02% | 683 |
|
|
2023
Q3 | – | Sell |
-547
| Closed | -$21.1K | – | 657 |
|
|
2023
Q2 | $21.1K | Buy |
+547
| New | +$21.1K | ﹤0.01% | 590 |
|